More than half of people eligible for potentially life-saving Covid-19 antiviral tablets know very little about the Government-subsidised treatments, a new Pfizer-funded survey suggests. Anti-viral medications Paxlovid, Lagevrio…
More than half of people eligible for potentially life-saving Covid-19 antiviral tablets know very little about the Government-subsidised treatments, a new Pfizer-funded survey suggests. Anti-viral medications Paxlovid, Lagevrio…